OpGen Inc
Change company Symbol lookup
Select an option...
OPGN OpGen Inc
THAR Tharimmune Inc
KITT Nauticus Robotics Inc
EAT Brinker International Inc
JCSE JE Cleantech Holdings Ltd
GVP GSE Systems Inc
CURV Torrid Holdings Inc
APRN Blue Apron Holdings Inc
BXRX Baudax Bio Inc
LAC Lithium Americas Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

Closing Price
$0.4006
Day's Change
0.1996 (99.30%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.5799
Day's Low
0.348
Volume
(Heavy Day)
Volume:
96,198,985

10-day average volume:
9,947,683
96,198,985

Canopy Growth Announces Fall 2023 Investor Conference and Event Participation

7:30 am ET September 13, 2023 (PR Newswire) Print

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced planned participation at investor conferences and events in September.

https://mma.prnewswire.com/media/2209307/Canopy_Growth_Corporation_Canopy_Growth_Announces_Fall_2023_Inve.jpg

Representatives of the Company will be presenting or in attendance at the following events:

ATB Capital Markets 2023 Life Sciences Institutional Investor Conference, September 20, 2023: CEO David Klein will participate in a fireside chat titled "Unleashing the Power of Brands in the US and Canada". Mr. Klein and Canopy Growth CFO Judy Hong will also participate in investor meetings on site.

Benzinga Cannabis Capital Conference, September 27 - 28, 2023: As the Company continues to advance its Canopy USA strategy, CEO David Klein will participate on a panel discussion titled "Market Analysis: Assessing the Right Time to Move into the U.S." on September 27. Mr Klein and CFO Judy Hong will also meet with investors, capital markets professionals and fellow industry participants while attending the event.

Alliance Global Partners Virtual Consumer Cannabis Conference, October 4, 2023: CEO David Klein and CFO Judy Hong will participate in the conference and attend investor meetings.

The Company plans to disclose additional investor conference participation for the remainder of the fall in due course.

About Canopy Growth

Canopy Growth is a leading North American cannabis and consumer packaged goods ("CPG") company dedicated to unleashing the power of cannabis to improve lives.

Through an unwavering commitment to our consumers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands including Doja, 7ACRES, Tweed, and Deep Space. Canopy Growth's CPG portfolio features sugar-free sports hydration brand BioSteel, targeted 24-hour skincare and wellness solutions from This Works, gourmet wellness products by Martha Stewart CBD, and category defining vaporizer technology made in Germany by Storz & Bickel.

Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through its rights to Acreage Holdings, Inc., a vertically integrated multi-state cannabis operator with principal operations in densely populated states across the Northeast, as well as Wana Brands, a leading cannabis edible brand in North America, and Jetty Extracts, a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology.

Beyond our world-class products, Canopy Growth is leading the industry forward through a commitment to social equity, responsible use, and community reinvestment—pioneering a future where cannabis is understood and welcomed for its potential to help achieve greater well-being and life enhancement.

For more information visit www.canopygrowth.com.

https://c212.net/c/img/favicon.png?sn=OT08264&sd=2023-09-13

View original content to download multimedia:https://www.prnewswire.com/news-releases/canopy-growth-announces-fall-2023-investor-conference-and-event-participation-301926125.html

SOURCE Canopy Growth Corporation

https://rt.newswire.ca/rt.gif?NewsItemId=OT08264&Transmission_Id=202309130730PR_NEWS_USPR_____OT08264&DateId=20230913

comtex tracking

COMTEX_440116677/1005/2023-09-13T07:30:44

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.